| Financial Year |
March 31 2023 |
| Monetary Funds |
133,296,792.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
166,984,096.74 |
| Advances to Suppliers |
223,769,242.73 |
| Other Receivables |
69,353,202.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,932,128.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
640,237.29 |
| Other Current Assets |
9,256,681.16 |
| Total Current Assets |
1,075,585,475.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
174,578.17 |
| Investment Properties |
-- |
| Fixed Assetes |
119,732,419.17 |
| Under-construction Projects |
27,038,395.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,006,966.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
319,139.65 |
| Deferred Income Tax Assets |
56,376,508.84 |
| Other Non-Current Assets |
249,996,110.92 |
| Sub-Total of Non-Current Assets |
499,569,764.51 |
| Total Assets |
1,575,155,240.46 |
| Short-Term Loans |
46,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,087,537.88 |
| Accounts Payable |
167,666,319.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,536,899.33 |
| Taxes Payable |
1,091,741.11 |
| Interest Payable |
-- |
| Dividend Payable |
5,478,603.10 |
| Other payables |
6,766,182.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,888,848.94 |
| Other Current Liabilities |
31,435,847.07 |
| Sub-Total of Current Liabilities |
566,068,900.39 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,163,153.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,351,040.94 |
| Total Liabilities |
583,419,941.33 |
| Paid-In Capital(Or Share Stock) |
160,691,993.00 |
| Capital Surplus |
791,140,232.79 |
| Surplus Reserve |
25,619,976.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-7,155,393.79 |
| Minority Stockholder's Interest |
8,093,324.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
983,641,975.12 |
| Owner's Equity（Stockholder's Equity） |
991,735,299.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,575,155,240.46 |
